Cargando…
Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
BACKGROUND/AIMS: To analyze the incidence and risk factors of outcomes after liver transplantation (LT) in the Korean population. METHODS: This study analyzed data from the liver cohort of Korean Organ Transplantation Registry (KOTRY) who had LT between May 2014 and December 2017. Study measures inc...
Autores principales: | Kim, Jong Man, Kim, Deok Gie, Kim, Jihyun, Lee, Keunsung, Lee, Kwang-Woong, Ryu, Je Ho, Kim, Bong-Wan, Choi, Dong Lak, You, Young Kyoung, Kim, Dong-Sik, Nah, Yang Won, Kang, Koo Jeong, Cho, Jai Young, Hong, Geun, Yu, Hee Chul, Moon, Ju Ik, Choi, Dongho, Hwang, Shin, Kim, Myoung Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273644/ https://www.ncbi.nlm.nih.gov/pubmed/33525077 http://dx.doi.org/10.3350/cmh.2020.0292 |
Ejemplares similares
-
Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022) -
Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database
por: Kang, Woo-Hyoung, et al.
Publicado: (2022) -
Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
por: Park, Gil-Chun, et al.
Publicado: (2020) -
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022) -
Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)